IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,264 | -10.2% | 12,800 | -0.8% | 0.01% | -11.1% |
| Q2 2023 | $137,256 | +12.5% | 12,900 | +11.2% | 0.01% | 0.0% |
| Q1 2023 | $122,032 | -3.4% | 11,600 | +13.7% | 0.01% | -10.0% |
| Q4 2022 | $126,378 | -15.2% | 10,200 | -29.2% | 0.01% | -23.1% |
| Q3 2022 | $149,000 | -36.9% | 14,400 | -29.8% | 0.01% | -38.1% |
| Q2 2022 | $236,000 | +5.4% | 20,500 | +15.2% | 0.02% | +16.7% |
| Q1 2022 | $224,000 | -13.2% | 17,800 | -19.5% | 0.02% | -10.0% |
| Q4 2021 | $258,000 | +6.6% | 22,100 | +19.5% | 0.02% | -9.1% |
| Q3 2021 | $242,000 | -6.9% | 18,500 | -8.4% | 0.02% | -8.3% |
| Q2 2021 | $260,000 | +18.7% | 20,200 | +3.1% | 0.02% | +9.1% |
| Q1 2021 | $219,000 | -35.0% | 19,600 | -33.8% | 0.02% | -40.5% |
| Q4 2020 | $337,000 | +42.2% | 29,600 | +12.5% | 0.04% | +23.3% |
| Q3 2020 | $237,000 | +13.4% | 26,300 | +29.6% | 0.03% | 0.0% |
| Q2 2020 | $209,000 | -29.4% | 20,300 | -30.7% | 0.03% | -41.2% |
| Q1 2020 | $296,000 | – | 29,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |